MCAM and small cell lung carcinoma: In a recent paper, CD146 was also identified as a markedly up-regulated surface receptor in chemoresistant small-cell lung cancer (SCLC) cell lines and in chemoresistant SCLC patient-derived xenografts compared to matched treatment-naïve tumors [10].